REQUEST A DEMO
Total
USD $0.00
Search more companies

Ewopharma Ag Sp. z o.o. (Poland)

Main Activities: Advertising Agencies
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Information Services | Administrative Management and General Management Consulting Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Marketing Research and Public Opinion Polling | All Other Professional, Scientific, and Technical Services | All Other Support Services | All Other Miscellaneous Ambulatory Health Care Services
Full name: Ewopharma Ag Sp. z o.o. Profile Updated: February 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Ewopharma Ag Sp. z o.o is a pharmaceutical company. The company focuses on introducing pharmaceutical and healthcare products to target markets in Central and Eastern Europe and Switzerland. Their range of products includes prescription drugs, specialized hospital medicines, generic drugs, and products for rare diseases, with a focus on gastroenterology, neuroscience, immunology, and oncology. They also offer medical marketing and brand management services, and have partnerships with companies such as Shield Therapeutics and Eisai Co., Ltd. to commercialize and develop pharmaceutical products. Some of their notable products include Revalid for hair care, Feraccru for the treatment of Iron Deficiency Anaemia, and ExAller for relieving allergic symptoms.

Headquarters
Ul. Leszno 14
Warsaw; Mazowieckie; Postal Code: 01-192

Contact Details: Purchase the Ewopharma Ag Sp. z o.o. report to view the information.

Website: http://www.ewopharma.pl

Basic Information
Total Employees:
Purchase the Ewopharma Ag Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Ewopharma Ag Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Ewopharma Ag Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Ewopharma Ag Sp. z o.o. report to view the information.
Incorporation Date:
February 07, 2002
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ewopharma Ag Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
17.74%
Total operating revenue
18.34%
Operating profit (EBIT)
33.77%
EBITDA
20.39%
Net Profit (Loss) for the Period
35.17%
Total assets
-8.74%
Total equity
-0.92%
Operating Profit Margin (ROS)
0.67%
Net Profit Margin
0.52%
Return on Equity (ROE)
5.6%
Quick Ratio
-0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?